Enzymotec USA Inc is categorized under Dairy and Non-Dairy Based Dietary Supplements in Morristown, NJ and active since 1997.
Enzymotec USA Inc was established in 1997, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Dairy and Non-Dairy Based Dietary Supplements business, which does work in the BOTH market, and is classified as a Dairy and Non-Dairy Based Dietary Supplements, under code number by the NAICS.
If you are seeking more information, feel free to contact Elzathan Hotam at the company’s single location by writing to 55 Madison Ave Suite 400, Morristown, New Jersey NJ 07960 or by phoning (973) 912-9400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Enzymotec USA Inc |
Contact Person: | Elzathan Hotam |
Address: | 55 Madison Ave Suite 400, Morristown, New Jersey 07960 |
Phone Number: | (973) 912-9400 |
Website Address: | enzymotec.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1997 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Dairy and Non-Dairy Based Dietary Supplements |
Share This Business: |
Enzymotec USA Inc was started in 1997 to provide professional Dairy and Non-Dairy Based Dietary Supplements under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Elzathan Hotam for inquiries that concern Enzymotec USA Inc by calling the company number (973) 912-9400, as your correspondence is most welcome. Additionally, the physical location of the single location of Enzymotec USA Inc can be found at the coordinates 40.78735,-74.46571 as well as the street address 55 Madison Ave Suite 400 in Morristown, New Jersey 07960.
For its online presence, you may visit Enzymotec USA Inc’s website at enzymotec.com and engage with its social media outlets through on Twitter and on Facebook.